Showing results (611-620 of 1,074) with videos related to

Sort By:
Pageof 108
JACC. Cardiovascular Interventions|August 25, 2018
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary AngiographyRoxana Mehran, Michela Faggioni, Jaya Chandrasekhar, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
International Journal of Molecular Sciences|February 13, 2025
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?Salvatore Giordano, Marina Camera, Marta Brambilla, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 23, 2013
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trialPilar Jiménez-Quevedo, Lorenzo Hernando, Joan Antoni Gómez-Hospital, et al.
Pageof 108